HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $556,585 | -4.4% | 4,811 | -15.0% | 0.00% | 0.0% |
Q2 2023 | $582,440 | -20.1% | 5,663 | -15.2% | 0.00% | -20.0% |
Q1 2023 | $729,055 | -28.6% | 6,680 | -25.6% | 0.01% | -37.5% |
Q4 2022 | $1,021,696 | +239.4% | 8,978 | +84.7% | 0.01% | +100.0% |
Q3 2022 | $301,000 | -30.6% | 4,862 | -10.6% | 0.00% | -33.3% |
Q2 2022 | $434,000 | -31.5% | 5,439 | -9.7% | 0.01% | -25.0% |
Q1 2022 | $634,000 | +1.9% | 6,025 | +4.4% | 0.01% | 0.0% |
Q4 2021 | $622,000 | +3.2% | 5,770 | +4.8% | 0.01% | 0.0% |
Q3 2021 | $603,000 | +4.9% | 5,508 | -10.3% | 0.01% | 0.0% |
Q2 2021 | $575,000 | +24.5% | 6,142 | +22.3% | 0.01% | -20.0% |
Q1 2021 | $462,000 | +57.7% | 5,021 | +25.2% | 0.01% | +42.9% |
Q4 2020 | $293,000 | +22.6% | 4,009 | +30.2% | 0.01% | +16.7% |
Q3 2020 | $239,000 | +43.1% | 3,079 | +2.3% | 0.01% | +50.0% |
Q2 2020 | $167,000 | – | 3,010 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |